Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.42 USD | +3.40% | +18.04% | -3.86% |
01/05 | Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts | MT |
01/05 | Transcript : TG Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024 |
Evolution of the average Target Price on TG Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering TG Therapeutics, Inc.
Goldman Sachs | |
B. Riley | |
HC Wainwright | |
JPMorgan Chase | |
Ladenburg Thalmann | |
Cantor Fitzgerald | |
Evercore ISI | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- TGTX Stock
- Consensus TG Therapeutics, Inc.